Press Releases

Date	Title	Company
05-Jun-2023	Teleradiology Services Market is expected to surpass US$ 5,598.3 Million and grow at 19% CAGR through 2032	MARKITWIRED
05-Jun-2023	Coronary Stents Market \| Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation \| By 2032	MARKITWIRED
05-Jun-2023	Positron Emission Tomography (PET) Scanners Market is rising to US$ 2.1 billion by 2033 likely to grow at a CAGR of 5.3%	MARKITWIRED
05-Jun-2023	Japan’s is Hypercalcemia Treatment Market offering lucrative growth opportunities and is expected to grow by 10.0% CAGR from 2022 to 2032	MARKITWIRED
05-Jun-2023	Special Purpose Needles Market in China is expected to grow at 8.3% CAGR during the forecast period 2022 to 2032	MARKITWIRED
05-Jun-2023	Regenerative Medicine Market \| 3M, Allergan plc, Amgen, Inc., Aspect Biosystems \| By 2032	MARKITWIRED
05-Jun-2023	Saudi Arabia Pharmaceutical Market is expected to flourish US$ 13,000 Million by 2032 at a CAGR of 9%	MARKITWIRED
05-Jun-2023	Antibodies Market is likely to be around US$ 834.2 Billion grow at a CAGR of 13.4% through 2033	MARKITWIRED
05-Jun-2023	BrainChip and Lorser Industries to Develop Neuromorphic Computing Systems for Software-Defined Radio Devices	Businesswire
04-Jun-2023	Reigniting the Cancer Moonshot: Massive Bio Joins CancerX as Founding Member to Accelerate Innovation and AI Implementation in Cancer Care	Businesswire
04-Jun-2023	Puma Biotechnology Announces Presentation of Biomarker Findings from a Phase II Study of Alisertib with Paclitaxel versus Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer at the 2023 ASCO Annual Meeting	Businesswire
04-Jun-2023	Nucleai and Mayo Clinic BioPharma Diagnostics Announce Strategic Collaboration to Transform Digital Pathology for Drug Development and Clinical Practice	Businesswire
04-Jun-2023	Four-Year Outcomes from Phase 3 CheckMate -9LA Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) with Two Cycles of Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer	Businesswire
03-Jun-2023	Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study	Businesswire
03-Jun-2023	Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study	Businesswire
03-Jun-2023	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of SentinelOne, Inc. (S) on Behalf of Investors	Businesswire
03-Jun-2023	Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery Reduced the Risk of Event-Free Survival Events by 42% Versus Pre-Operative Chemotherapy in Resectable Stage II, IIIA or IIIB NSCLC	Businesswire
03-Jun-2023	Massive Bio and The Oncology Institute (TOI) Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research	Businesswire
03-Jun-2023	KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Unresectable Advanced Pleural Mesothelioma	Businesswire
03-Jun-2023	Rapid Dose Announces Proposed Private Placement Financing	Businesswire